William Ridgway Appointed Director of UC's Division of Immunology
William Ridgway, MD, has been appointed director of the division of immunology at the University of Cincinnati (UC)
Ridgway was previously an associate professor of medicine, with tenure, in the division of rheumatology and clinical immunology at the University of Pittsburgh School of Medicine where he researched the genetics and cellular immunology of autoimmunity. He focuses primarily on investigating mouse models with spontaneous autoimmune syndromes such as type 1 diabetes and autoimmune liver disease. He was also a principal investigator within the National Institutes of Health (NIH) funded Autoimmunity Center of Excellence at the
From 1998 to 2003, Ridgway served as chief of the rheumatology division at the
I am very excited to have Dr. Ridgway lead UCs division of immunology, says David Stern, MD, vice president for health affairs at UC and dean of the
He will be a welcome addition to the leadership team of the
Ridgway received his medical degree from the
He has collaborated with many physicians, nationally and internationally, on basic research, particularly in the areas of autoimmunity and autoimmune phenotypes. Additionally, Ridgway has retained repeated research support through grants from the NIH.
During his career, Ridgway has received several distinguished awards including the
highly competitive Pfizer Scholars Grant for new faculty and Juvenile Diabetes Foundation International Career Development Award. He is a member of the
I am pleased and honored to join the Division of Immunology at University of Cincinnati Academic Health Center, Ridgway says. I look forward to starting new research initiatives in lupus, allergy and the immunogenetics of autoimmune disease.
Ridgway replaces John Houk, MD, interim director of the immunology division.
Related Stories
Is speech-to-text AI really reliable?
July 10, 2026
UC researcher Nelly Elsayed’s study in the International Journal of Medical Informatics reveals key risks in clinical speech-to-text AI and shows why human review is essential.
Hoxworth Blood Center CEO advocates on Capitol Hill during National Blood Advocacy Week
July 9, 2026
Hoxworth Blood Center, University of Cincinnati, has announced that David Oh, MD, director and chief executive officer, joined blood center leaders, patient advocates and partner organizations in Washington, D.C., in June as part of Blood Advocacy Week, a national initiative led by America’s Blood Centers to strengthen the nation’s blood supply.
Suzanne Judd, PhD, officially arrives as inaugural director of the UC Center for Public Health
July 6, 2026
The University of Cincinnati welcomes renowned epidemiologist Suzanne E. Judd, PhD, as the inaugural director of the new UC Center for Public Health.